KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 126 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q1 2015. The put-call ratio across all filers is 1.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $12,010,000 | -6.4% | 160,181 | -6.0% | 1.16% | +1.0% |
| Q2 2015 | $12,837,000 | +46.7% | 170,454 | -2.3% | 1.14% | +49.2% |
| Q1 2015 | $8,749,000 | -99.9% | 174,454 | -1.1% | 0.77% | +48.4% |
| Q4 2014 | $6,119,425,000 | +105754.1% | 176,454 | 0.0% | 0.52% | -4.4% |
| Q3 2014 | $5,781,000 | -14.6% | 176,454 | 0.0% | 0.54% | -14.1% |
| Q2 2014 | $6,771,000 | -3.5% | 176,454 | 0.0% | 0.63% | -7.9% |
| Q1 2014 | $7,016,000 | -2.9% | 176,454 | -8.8% | 0.68% | -2.0% |
| Q4 2013 | $7,226,000 | – | 193,454 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 34,925 | $1,596,000 | 1.83% |
| Redmile Group, LLC | 228,218 | $10,430,000 | 1.57% |
| Palo Alto Investors LP | 319,113 | $14,548,000 | 1.52% |
| Aureus Asset Management, LLC | 92,350 | $4,210,000 | 1.44% |
| PFM Health Sciences, LP | 767,892 | $35,007,000 | 0.84% |
| EAM Investors, LLC | 60,219 | $2,752,000 | 0.55% |
| INVESTOR AB | 80,000 | $3,540,000 | 0.41% |
| Partner Investment Management, L.P. | 23,595 | $1,076,000 | 0.29% |
| Polar Capital LLP | 230,000 | $10,511,000 | 0.28% |
| Old West Investment Management, LLC | 11,130 | $507,000 | 0.24% |